First Manhattan’s Curis CRIS Stock Holding History

First Manhattan’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-2	Closed	-$8K	–	1410
2013 Q4	$8K	Hold	2	–	–	﹤0.01%	1186
2013 Q3	$13K	Hold	2	–	–	﹤0.01%	1129
2013 Q2	$11K	Buy	+2	New	+$14.1K	﹤0.01%	1139

Other funds holding CRIS

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Manhattan's CRIS Position: Q1 2014 in Review

First Manhattan sold out of Curis (CRIS) in Q1 2014, closing a stake of 2 shares — an estimated $8K sold.

First Manhattan first reported a position in CRIS in Q2 2013 and held it in 3 quarters. The position peaked at $13K in Q3 2013. 84 funds tracked by Wall St. Rank hold CRIS as of Q1 2014.

First Manhattan reported no remaining Curis position as of Q1 2014 after selling out during the quarter.
First Manhattan sold 2 Curis shares in Q1 2014, an estimated $8K.
First Manhattan first reported a position in Curis in Q2 2013 and held it in 3 quarters.
First Manhattan's Curis position peaked at $13K in Q3 2013.
84 funds tracked by Wall St. Rank held Curis as of Q1 2014.

Based on First Manhattan's 13F filing for Q1 2014, filed 16 May 2014.